Identification of a post‐translational modification with ribitol‐phosphate and its defect in muscular dystrophy: Roles of ISPD, fukutin, and FKRP in α‐dystroglycan glycosylation

[1]  F. Negm,et al.  Partial Purification and Characterization of d-Ribose-5-phosphate Reductase from Adonis vernalis L. Leaves. , 1985, Plant physiology.

[2]  O. Ibraghimov-Beskrovnaya,et al.  Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix , 1992, Nature.

[3]  I. Kanazawa,et al.  Structures of Sialylated O-Linked Oligosaccharides of Bovine Peripheral Nerve α-Dystroglycan , 1997, The Journal of Biological Chemistry.

[4]  I. Kanazawa,et al.  Structures of sialylated O-linked oligosaccharides of bovine peripheral nerve alpha-dystroglycan. The role of a novel O-mannosyl-type oligosaccharide in the binding of alpha-dystroglycan with laminin. , 1997, The Journal of biological chemistry.

[5]  I. Kanazawa,et al.  An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy , 1998, Nature.

[6]  Shun–ichi Kobayashi.  Tokyo campus rising , 1998, Nature.

[7]  K. Campbell,et al.  Identification of alpha-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus. , 1998, Science.

[8]  S. Munro,et al.  Activity of the yeast MNN1 alpha-1,3-mannosyltransferase requires a motif conserved in many other families of glycosyltransferases. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[9]  E. Koonin,et al.  The fukutin protein family – predicted enzymes modifying cell-surface molecules , 1999, Current Biology.

[10]  Susan C. Brown,et al.  Mutations in the fukutin-related protein gene (FKRP) identify limb girdle muscular dystrophy 2I as a milder allelic variant of congenital muscular dystrophy MDC1C. , 2001, Human molecular genetics.

[11]  Susan C. Brown,et al.  Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin alpha2 deficiency and abnormal glycosylation of alpha-dystroglycan. , 2001, American journal of human genetics.

[12]  M. Mizuno,et al.  Muscular dystrophy and neuronal migration disorder caused by mutations in a glycosyltransferase, POMGnT1. , 2001, Developmental cell.

[13]  K. Campbell,et al.  Post-translational disruption of dystroglycan–ligand interactions in congenital muscular dystrophies , 2002, Nature.

[14]  J. Mendell,et al.  Disruption of Dag1 in Differentiated Skeletal Muscle Reveals a Role for Dystroglycan in Muscle Regeneration , 2002, Cell.

[15]  Susan C. Brown,et al.  Functional requirements for fukutin-related protein in the Golgi apparatus. , 2002, Human molecular genetics.

[16]  K. Campbell,et al.  Deletion of brain dystroglycan recapitulates aspects of congenital muscular dystrophy , 2002, Nature.

[17]  R. U. Margolis,et al.  Demonstration of mammalian protein O-mannosyltransferase activity: coexpression of POMT1 and POMT2 required for enzymatic activity. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[18]  K. Campbell,et al.  Molecular Recognition by LARGE Is Essential for Expression of Functional Dystroglycan , 2004, Cell.

[19]  K. Campbell,et al.  Proteolytic Enzymes and Altered Glycosylation Modulate Dystroglycan Function in Carcinoma Cells , 2004, Cancer Research.

[20]  H. Otani,et al.  Basement membrane fragility underlies embryonic lethality in fukutin-null mice , 2005, Neurobiology of Disease.

[21]  K. Campbell,et al.  Congenital muscular dystrophy with glycosylation defects of alpha-dystroglycan in Japan. , 2005, Neuromuscular disorders : NMD.

[22]  I. Nonaka,et al.  Congenital muscular dystrophy with glycosylation defects of α-dystroglycan in Japan , 2005, Neuromuscular Disorders.

[23]  R. Carlier,et al.  Brain MRI abnormalities in muscular dystrophy due to FKRP mutations , 2006, Brain and Development.

[24]  F. Muntoni,et al.  Reduced expression of fukutin related protein in mice results in a model for fukutin related protein associated muscular dystrophies. , 2008, Brain : a journal of neurology.

[25]  J. Marles-Wright,et al.  Synthesis of Cdp-activated Ribitol For , 2008 .

[26]  Leszek Rychlewski,et al.  Comprehensive classification of nucleotidyltransferase fold proteins: identification of novel families and their representatives in human , 2009, Nucleic acids research.

[27]  M. Fukuda,et al.  Tumor suppressor function of laminin-binding α-dystroglycan requires a distinct β3-N-acetylglucosaminyltransferase , 2009, Proceedings of the National Academy of Sciences.

[28]  Liping Yu,et al.  O-Mannosyl Phosphorylation of Alpha-Dystroglycan Is Required for Laminin Binding , 2010, Science.

[29]  S. Dimauro,et al.  Pathogenic exon-trapping by SVA retrotransposon and rescue in Fukuyama muscular dystrophy , 2011, Nature.

[30]  F. Muntoni,et al.  A dystroglycan mutation associated with limb-girdle muscular dystrophy. , 2011, The New England journal of medicine.

[31]  L. Wells,et al.  Synthetic, structural, and biosynthetic studies of an unusual phospho-glycopeptide derived from α-dystroglycan. , 2011, Journal of the American Chemical Society.

[32]  K. Campbell,et al.  Like-acetylglucosaminyltransferase (LARGE)-dependent modification of dystroglycan at Thr-317/319 is required for laminin binding and arenavirus infection , 2011, Proceedings of the National Academy of Sciences.

[33]  Liping Yu,et al.  Dystroglycan Function Requires Xylosyl- and Glucuronyltransferase Activities of LARGE , 2012, Science.

[34]  Christian Gilissen,et al.  Mutations in ISPD cause Walker-Warburg syndrome and defective glycosylation of α-dystroglycan , 2012, Nature Genetics.

[35]  T. Toda,et al.  Mislocalization of Fukutin Protein by Disease-causing Missense Mutations Can Be Rescued with Treatments Directed at Folding Amelioration* , 2012, The Journal of Biological Chemistry.

[36]  M. Tajiri,et al.  Absence of Post-phosphoryl Modification in Dystroglycanopathy Mouse Models and Wild-type Tissues Expressing Non-laminin Binding Form of α-Dystroglycan* , 2012, The Journal of Biological Chemistry.

[37]  Francesco Muntoni,et al.  ISPD loss-of-function mutations disrupt dystroglycan O-mannosylation and cause Walker-Warburg syndrome , 2012, Nature Genetics.

[38]  M. Hurles,et al.  ISPD gene mutations are a common cause of congenital and limb-girdle muscular dystrophies , 2013, Brain : a journal of neurology.

[39]  S. Walker,et al.  Wall teichoic acids of gram-positive bacteria. , 2013, Annual review of microbiology.

[40]  K. Naruse,et al.  Impaired viability of muscle precursor cells in muscular dystrophy with glycosylation defects and amelioration of its severe phenotype by limited gene expression. , 2013, Human molecular genetics.

[41]  S. Nelson,et al.  SGK196 Is a Glycosylation-Specific O-Mannose Kinase Required for Dystroglycan Function , 2013, Science.

[42]  M. Goddeeris,et al.  LARGE glycans on dystroglycan function as a tunable matrix scaffold to prevent dystrophy , 2013, Nature.

[43]  J. Carette,et al.  Deciphering the Glycosylome of Dystroglycanopathies Using Haploid Screens for Lassa Virus Entry , 2013, Science.

[44]  Liping Yu,et al.  The glucuronyltransferase B4GAT1 is required for initiation of LARGE-mediated α-dystroglycan functional glycosylation , 2014, eLife.

[45]  Jeremy L. Praissman,et al.  B4GAT1 is the priming enzyme for the LARGE-dependent functional glycosylation of α-dystroglycan , 2014, eLife.

[46]  K. Campbell,et al.  Matriglycan: a novel polysaccharide that links dystroglycan to the basement membrane , 2015, Glycobiology.

[47]  Patrick Breheny,et al.  Downregulation of dystroglycan glycosyltransferases LARGE2 and ISPD associate with increased mortality in clear cell renal cell carcinoma , 2015, Molecular Cancer.